News Release

Thank you very much for accessing the website of Fukuzyu Pharmaceutical Co., Ltd.

 

We participated in the "Toyama Healthcare Venture Meetup in Tokyo 2025" held at Hotel Chinzanso Tokyo on January 28, 2025.

This event was held in conjunction with the "Toyama Business Location Seminar in Tokyo", and about 30 people related to healthcare venture companies based in Toyama Prefecture and outside the prefecture participated.

 

Our company took the stage in the second part of the event and explained to the participants about our business overview, case studies, collaboration needs, and our strengths.

The summary of presentation on the day is as below.

 

 

[Business content]

Fukuzyu Pharmaceutical was founded in Toyama City in 1950 and celebrates its 75th anniversary this year.

Specializing in supporting the development of small molecule drugs, we have been working on contract manufacturing of pharmaceutical intermediates and active pharmaceutical ingredients from non-clinical to commercial use while brushing up our GMP system.

In recent years, we have been actively engaged in contract manufacturing of chemical synthesis products necessary for the development of nucleic acid and peptide antibody drugs, and also conducting research of flow synthesis technology.

[Our strengths]

Our strengths are impetus and flexibility, and we offer flexible support from the early stages of development based on our business principle.

In recent years, we have received more consultations about modified amidites (nucleic acids), amino acid intermediates (peptides), payload intermediates (ADC), lipid nanoparticles (DDS), high-molecular purification, etc., and we are also gaining experience in new fields.